Abstract
The UK government's plan to define criteria by which new medicines could qualify for a pilot 'Innovation Pass' programme highlights recent discussions in Europe on the value of innovation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Hughes, B. Defining innovation. Nat Rev Drug Discov 8, 683–684 (2009). https://doi.org/10.1038/nrd2993
Issue Date:
DOI: https://doi.org/10.1038/nrd2993
This article is cited by
-
2009 in reflection
Nature Reviews Drug Discovery (2010)
-
News in brief
Nature Reviews Drug Discovery (2009)